Brazil Diabetes Care Devices Market Analysis and Forecasts to 2015
Summary
GlobalData’s medical device report: “Brazil Diabetes Care Devices Market Analysis and Forecasts to 2015” report provides key data, information and analysis on the Brazil diabetes care devices market. The report provides market landscape, competitive landscape and market trends information on two market categories – glucose monitoring and insulin delivery. The report provides comprehensive information on the key trends affecting these categories, and key analytical insight on the market dynamics. The report also reviews the competitive landscape in terms of mergers and acquisitions, pipeline products and technology offerings.
Scope
- Forecasts & Analysis of the Brazil diabetes care devices market to 2015.
- Market segmentation by glucose monitoring and insulin delivery. Glucose monitoring further segmented into blood glucose meters and blood glucose test strips. Insulin delivery further segmented into insulin pens, insulin pumps, insulin syringes and traditional insulin pump accessories.
- Market Analysis from 2001 to 2008, including new updated 2008 data.
- Analysis of the leading companies and competitive landscape including 2008 company market share analysis.
- Analysis of key diabetes care pipeline products, new technologies and clinical trials.
- Insight into the key mergers and acquisitions (M&As), partnerships, venture capital and private equity investments.
- Qualitative analysis of market drivers, market limiters regulatory issues and future outlook.
Reasons to buy
- Understand what the new growth opportunities are within the Brazil diabetes care devices market.
- Develop a clear knowledge & understanding of the Brazil diabetes care devices competitor landscape and how this will change to 2015.
- Identify acquisition opportunities across the Brazil diabetes care devices market.
- Identify key winners and losers and who is best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
Keywords
brazil health structure, diabetes market, glucose monitoring, insulin delivery, pens, pumps, meters, strips, distribution, average price, value, competitive analysis, company share, market share, average price, pipeline products, drivers, restraints, volume, F. Hoffmann-La Roche Ltd., LifeScan, Inc., Abbott Laboratories, Bayer HealthCare AG, Becton, Dickinson and Company, Medtronic, Inc., Eli Lilly and Company, Novo Nordisk A/S, Terumo Corporation, Animas Corporation, Sanofi-Aventis, Apex Biotechnology Corp., Smiths Medical.
Medical Equipment And Supply Industry in Brazil
Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 8
2 Introduction 9
2.1 What Is This Report About? 9
3 Executive Summary 10
4 Definitions of Markets Covered in the Report 11
4.1 Diabetic Care Devices 11
4.2 Glucose Monitoring Devices 11
4.2.1 Blood Glucose Meters 11
4.2.2 Blood Glucose Strips 11
4.3 Insulin Delivery 11
4.3.1 Insulin Pens 11
4.3.2 Insulin Syringes 12
4.3.3 Insulin Pumps 12
4.3.4 Traditional Insulin Pump Accessories 12
5 Healthcare Sector Review 13
5.1 Healthcare Expenditure 13
5.2 Healthcare Infrastructure 14
5.3 Healthcare Policy 14
6 Regulation System 15
6.1 Medical Device Registration Protocol 15
6.1.1 Registration Documentation 15
6.1.2 Registration Procedure 16
6.1.3 Medical Device Registration Fee 17
7 Pricing and Reimbursement 18
8 Distribution Structure 19
9 Diabetes Care Devices In Brazil 20
9.1 Diabetes Care Devices, Brazil, Overall Revenue ($ m), 2000-2015 20
9.2 Diabetes Care Devices, Brazil, Category Volume (Units), 2000-2015 23
9.3 Diabetes Care Devices, Brazil, Cross-Category Analysis, 2000-2015 25
9.4 Diabetes Care Devices, Brazil, Company Share (2007-2008) 26
10 Glucose Monitoring In Brazil 27
10.1 Glucose Monitoring Overall Revenue (2000-2015) 27
10.2 Glucose Monitoring Overall Volume (2000-2015) 30
10.3 Glucose Monitoring Average Price (2000-2015) 32
10.4 Glucose Monitoring Market Dynamics 33
10.5 Glucose Monitoring Distribution Share (2007-2008) 33
10.6 Glucose Monitoring, Brazil, Company Share (2007-2008) 34
11 Insulin Delivery In Brazil 35
11.1 Insulin Delivery Overall Revenue (2000-2015) 35
11.1.1 Insulin Pens Overall Revenue (2000-2015) 39
11.2 Insulin Delivery Overall Volume (2000-2015) 41
11.2.1 Insulin Pens Overall Volume (2000-2015) 43
11.3 Insulin Delivery Average Price (2000-2015) 45
11.4 Insulin Delivery Market Dynamics 46
11.5 Insulin Delivery Distribution Share (2007-2008) 47
11.6 Insulin Delivery, Brazil, Company Share (2007-2008) 48
12 Overview of Key Companies in Brazil Diabetes Care Devices Market 49
12.1 F. Hoffmann-La Roche Ltd. 49
12.1.1 Company Overview 49
12.1.2 Value Chain Analysis 49
12.1.3 F. Hoffmann-La Roche Ltd Pipeline Products 52
12.2 LifeScan, Inc. 53
12.2.1 Company Overview 53
12.2.2 LifeScan, Inc. Pipeline Products 53
12.3 Abbott Laboratories 55
12.3.1 Company Overview 55
12.3.2 Value Chain Analysis 55
12.3.3 Abbott Laboratories Pipeline Products 57
12.4 Bayer HealthCare AG 59
12.4.1 Company Overview 59
12.4.2 Value Chain Analysis 59
12.4.3 Bayer HealthCare AG Pipeline Products 61
12.5 Becton, Dickinson and Company 63
12.5.1 Company Overview 63
12.5.2 Value Chain Analysis 63
12.6 Medtronic, Inc. 65
12.6.1 Company Overview 65
12.6.2 Value Chain Analysis 66
12.6.3 Medtronic, Inc. Pipeline Products 67
12.7 Eli Lilly and Company 75
12.7.1 Company Overview 75
12.7.2 Value Chain Analysis 75
12.7.3 Eli Lilly and Company Pipeline Products 78
12.8 Novo Nordisk A/S 79
12.8.1 Company Overview 79
12.8.2 Novo Nordisk A/S Pipeline Products 79
12.9 Terumo Corporation 81
12.9.1 Company Overview 81
12.9.2 Value Chain Analysis 81
12.10 Animas Corporation 83
12.10.1 Company Overview 83
12.11 Sanofi-Aventis 83
12.11.1 Company Overview 83
12.12 Apex Biotechnology Corp. 84
12.12.1 Company Overview 84
12.13 Smiths Medical 84
12.13.1 Company Overview 84
12.13.2 Value Chain Analysis 85
13 Appendix 87
13.1 GlobalData Research Methodology 87
13.2 Coverage 88
13.3 Secondary Research 89
13.4 Primary Research 89
13.5 Models 90
13.6 Forecasts 90
13.7 Expert Panel Validation 91
13.8 Currency Conversion 92
13.9 Contact Us 93
13.10 Disclaimer 93
List of Tables
1.1 List of Tables
Table 1: Medical Device Registration Fee in Brazil, 2002 17
Table 2: Diabetes Care Devices, Brazil, Overall Revenue ($ m), Historic, 2000-2008 20
Table 3: Diabetes Care Devices, Brazil, Overall Revenue ($ m), Forecast, 2008-2015 22
Table 4: Diabetes Care Devices, Brazil, Category Volume (Units), Historic, 2000-2008 23
Table 5: Diabetes Care Devices, Brazil, Category Volume (Units), Forecast, 2008-2015 24
Table 6: Diabetes Care Devices, Brazil, Cross-Category Analysis, 2000-2015 25
Table 7: Diabetes Care Devices, Brazil, Company Share by Revenue ($ m), 2007-2008 26
Table 8: Glucose Monitoring, Brazil, Revenue ($ m) by Segment, Historic, 2000-2008 27
Table 9: Glucose Monitoring, Brazil, Revenue ($ m) by Segment, Forecast, 2008-2015 29
Table 10: Glucose Monitoring, Brazil, Volume (Units) by Segment, Historic, 2000-2008 30
Table 11: Glucose Monitoring, Brazil, Volume (Units) by Segment, Forecast, 2008-2015 31
Table 12: Glucose Monitoring, Brazil, Average Price ($), Historic, 2000-2008 32
Table 13: Glucose Monitoring, Brazil, Average Price ($), Forecast, 2008-2015 32
Table 14: Glucose Monitoring, Brazil, Distribution Share by Revenue ($ m), 2007-2008 33
Table 15: Glucose Monitoring, Brazil, Company Share by Revenue ($ m), 2007-2008 34
Table 16: Insulin Delivery, Brazil, Revenue ($ m) by Segment, Historic, 2000-2008 35
Table 17: Insulin Delivery, Brazil, Revenue ($ m) by Segment, Forecast, 2008-2015 37
Table 18: Insulin Pens, Brazil, Revenue ($ m) by Sub-Segment, Historic, 2000-2008 39
Table 19: Insulin Pens, Brazil, Revenue ($ m) by Sub-Segment, Forecast, 2008-2015 40
Table 20: Insulin Delivery, Brazil, Volume (Units) by Segment, Historic, 2000-2008 41
Table 21: Insulin Delivery, Brazil, Volume (Units) by Segment, Forecast, 2008-2015 41
Table 22: Insulin Pens, Brazil, Volume (Units) by Sub-Segment, Historic, 2000-2008 43
Table 23: Insulin Pens, Brazil, Volume (Units) by Sub-Segment, Forecast, 2008-2015 44
Table 24: Insulin Delivery, Brazil, Average Price ($), Historic, 2000-2008 45
Table 25: Insulin Delivery, Brazil, Average Price ($), Forecast, 2008-2015 45
Table 26: Insulin Delivery, Brazil, Distribution Share by Revenue ($m), 2007-2008 47
Table 27: Insulin Delivery, Brazil, Company Share by Revenue ($ mn), 2007-2008 48
Table 28: F. Hoffmann-La Roche Ltd Pipeline Products by Equipment Type 52
Table 29: F. Hoffmann-La Roche Ltd Pipeline Products by Development Stage 52
Table 30: F. Hoffmann-La Roche Ltd Pipeline Products by Therapy Area 52
Table 31: LifeScan, Inc. Pipeline Products by Equipment Type 53
Table 32: LifeScan, Inc. Pipeline Products by Development Stage 53
Table 33: LifeScan, Inc. Pipeline Products by Therapy Area 53
Table 34: LifeScan, Inc. Pipeline Products by Clinical Trials 54
Table 35: LifeScan, Inc. Pipeline Products by News Summary 54
Table 36: Abbott Laboratories Pipeline Products by Equipment Type 57
Table 37: Abbott Laboratories Pipeline Products by Development Stage 58
Table 38: Abbott Laboratories Pipeline Products by Therapy Area 58
Table 39: Abbott Laboratories Pipeline Products by Clinical Trials 58
Table 40: Abbott Laboratories Pipeline Products by News Summary 58
Table 41: Bayer HealthCare AG Pipeline Products by Equipment Type 61
Table 42: Bayer HealthCare AG Pipeline Products by Development Stage 62
Table 43: Bayer HealthCare AG Pipeline Products by Therapy Area 62
Table 44: Bayer HealthCare AG Pipeline Products by News Summary 62
Table 45: Medtronic, Inc. Pipeline Products by Equipment Type 67
Table 46: Medtronic, Inc. Pipeline Products By Development Stage 69
Table 47: Medtronic, Inc. Pipeline Products By Therapy Area 71
Table 48: Medtronic, Inc. Pipeline Products By Clinical Trials 73
Table 49: Medtronic, Inc. Pipeline Products By News Summary 74
Table 50: Eli Lilly and Company Pipeline Products by Equipment Type 78
Table 51: Eli Lilly and Company Pipeline Products by Development Stage 78
Table 52: Eli Lilly and Company Pipeline Products by Therapy Area 78
Table 53: Eli Lilly and Company Pipeline Products by Clinical Trials 78
Table 54: Eli Lilly and Company Pipeline Products by News Summary 78
Table 55: Novo Nordisk A/S Pipeline Products by Equipment Type 79
Table 56: Novo Nordisk A/S Pipeline Products By Development Stage 79
Table 57: Novo Nordisk A/S Pipeline Products By Therapy Area 80
Table 58: Novo Nordisk A/S Pipeline Products By Clinical Trials 80
Table 59: USD to Local Currency, Average Exchange Rate 2008 92
List of Figures
1.2 List of Figures
Figure 1: Health Expenditure by Source in Brazil 14
Figure 2: Diabetes Care Devices, Brazil, Overall Revenue ($ m), Historic, 2000-2008 20
Figure 3: Diabetes Care Devices, Brazil, Overall Revenue ($ m), Forecast, 2008-2015 22
Figure 4: Diabetes Care Devices, Brazil, Category Volume (Units), Historic, 2000-2008 23
Figure 5: Diabetes Care Devices, Brazil, Category Volume (Units), Forecast, 2008-2015 24
Figure 6: Diabetes Care Devices, Brazil, Cross-Category Analysis, 2000-2015 25
Figure 7: Diabetes Care Devices, Brazil, Company Share (%), 2008 26
Figure 8: Glucose Monitoring, Brazil, Revenue ($ m) by Segment, Historic, 2000-2008 27
Figure 9: Glucose Monitoring, Brazil, Revenue ($ m) by Segment, Forecast, 2008-2015 29
Figure 10: Glucose Monitoring, Brazil, Volume (Units) by Segment, Historic, 2000-2008 30
Figure 11: Glucose Monitoring, Brazil, Volume (Units) by Segment, Forecast, 2008-2015 31
Figure 12: Glucose Monitoring, Brazil, Company Share (%), 2008 34
Figure 13: Insulin Delivery, Brazil, Revenue ($ m) by Segment, Historic, 2000-2008 35
Figure 14: Insulin Delivery, Brazil, Revenue ($ m) by Segment, Forecast, 2008-2015 37
Figure 15: Insulin Pens, Brazil, Revenue ($ m) by Sub-Segment, Historic, 2000-2008 39
Figure 16: Insulin Pens, Brazil, Revenue ($ m) by Sub-Segment, Forecast, 2008-2015 40
Figure 17: Insulin Pens, Brazil, Volume (Units) by Sub-Segment, Historic, 2000-2008 43
Figure 18: Insulin Pens, Brazil, Volume (Units) by Sub-Segment, Forecast, 2008-2015 44
Figure 19: Insulin Delivery, Brazil, Company Share (%), 2008 48
Figure 20: GlobalData Methodology 88
